Aniracetam
Specifications
72432-10-1CAS Number
615-758-3EC Number
1-(4-methoxybenzoyl)pyrrolidin-2-oneIUPAC Name
C12H13NO3Chemical Formula
219.24 g/molMolecular Weight
aniracetam; 72432-10-1; Draganon; Sarpul; 1-(4-Methoxybenzoyl)-2-pyrrolidinone; Ro 13-5057; 1-p-Anisoyl-2-pyrrolidinone; Ro-13-5057; 1-anisoyl-2-pyrrolidinone; 1-p-anisoylpyrrolidin-2-one; DTXSID5045128; NSC-758223; 5L16LKN964; Ro-135057; DTXCID3025128; CHEBI:47943; 1-[(4-methoxyphenyl)carbonyl]pyrrolidin-2-one; 1-((4-methoxyphenyl)carbonyl)pyrrolidin-2-one; aniracetamum; RefChem:558129; N06BX11; 1-(4-methoxybenzoyl)pyrrolidin-2-one; Ampamet; 2-Pyrrolidinone, 1-(4-methoxybenzoyl)-; MFCD00153767; MLS000079240; aniracetam;p-methoxybenzoyl-2-pirrolidone; NCGC00015116-10; SMR000038438; Aniracetamun; Memodrin; Aniracetamun [INN-Latin]; Aniracetam [USAN:INN:JAN]; CAS-72432-10-1; SR-01000003147; Ro 135057; BRN 4807205; Sarpol; Reset; UNII-5L16LKN964; Draganon;; Ampamet;; Reset;; 1-(p-Methoxybenzoyl)-2-pyrrolidinon [German]; 1-(p-Methoxybenzoyl)-2-pyrrolidinon; Aniracetam (Standard); Spectrum_001342; Tocris-0867; Aniracetam, >=98%; ANIRACETAM [MI]; Opera_ID_294; ANIRACETAM [INN]; ANIRACETAM [JAN]; Spectrum3_001553; Spectrum4_000761; Spectrum5_001609; ANIRACETAM [USAN]; Lopac-A-9950; Biomol-NT_000222; ANIRACETAM [MART.]; ANIRACETAM [WHO-DD]; Lopac0_000115; SCHEMBL70998; BSPBio_003026; KBioGR_001142; KBioSS_001822; MLS000028591; MLS001201800; Aniracetam (JAN/USAN/INN); CHEMBL36994; DivK1c_000403; SPECTRUM1503078; Aniracetam - Bio-X trade mark; BPBio1_001316; GTPL4133; orb1224140; orb1310712; SCHEMBL11379053; HMS501E05; KBio1_000403; KBio2_001822; KBio2_004390; KBio2_006958; KBio3_002526; NINDS_000403; GLXC-06465; HMS2089O17; HMS2094K07; HMS2234E11; HMS3260G12; HMS3266L08; HMS3411P17; HMS3657G11; HMS3675P17; HMS3713N20; HMS3884C09; HMS5079L05; Pharmakon1600-01503078; MSK10891; Tox21_110086; Tox21_500115; 1-(4-Methoxybenzoyl)-2-pyrrolidone; HB0116; HY-10932R; NSC758223; s1281; 1-(p-methoxybenzoyl)-2-pyrrolidinone; AKOS005066313; Tox21_110086_1; AB04115; CCG-204210; CS-1793; DB04599; FA17937; KS-5313; LP00115; NSC 758223; SDCCGSBI-0050103.P005; IDI1_000403; NCGC00015116-01; NCGC00015116-02; NCGC00015116-03; NCGC00015116-04; NCGC00015116-05; NCGC00015116-06; NCGC00015116-07; NCGC00015116-08; NCGC00015116-09; NCGC00015116-11; NCGC00015116-12; NCGC00015116-13; NCGC00015116-15; NCGC00015116-24; NCGC00021402-02; NCGC00021402-05; NCGC00021402-06; NCGC00021402-07; NCGC00021402-08; NCGC00260800-01; Ro-13-3057; 1-(4-Methoxy-benzoyl)-pyrrolidin-2-one; 1-(4-Methoxybenzoyl)-2-pyrrolidinone #; AC-15651; BA164183; HY-10932; SY052612; SBI-0050103.P004; A2394; A5326; EU-0100115; NS00017748; SW199095-2; A 9950; D01883; H10883; AB00053303-14; AB00053303_15; AB00053303_16; ANIRACETAM; 1-P-ANISOYL-2-PYRROLIDINONE; F859371; Q417630; SR-01000003147-2; SR-01000003147-4; SR-01000003147-6; SR-01000003147-8; BRD-K88611939-001-02-6; BRD-K88611939-001-13-3; BRD-K88611939-001-22-4; BRD-K88611939-001-23-2Synonyms